Primary Record
Rabusertib
- In stock
- 5,570 g
- Purity
- 99.7 %
- CAS
- 911222-45-2
Compound Identifiers & Properties
- CAS
- 911222-45-2
- PubChem CID
- 11955855
- SMILES
- CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OC[C@@H]3CNCCO3
- Canonical SMILES
- Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1
Names & Synonyms
- Rabusertib
- LY2603618
- 911222-45-2
- Rabusertib [USAN]
- Rabusertib [USAN:INN]
- Rabusertib (LY2603618)
- IC-83
- RABUSERTIB [INN]
- Rabusertib (USAN/INN)
- RefChem:872119
- 3S9L1NU6U7
- UNII-3S9L1NU6U7
- LY 2603618
- LY-2603618
- D00NZL
- RABUSERTIB [WHO-DD]
- C18H22BrN5O3
- cc-579
- MLS006011026
- SCHEMBL304747
- DTXSID50238417
- MFCD18633253
- GTPL7960
- orb1301087
- ly2603618 IC-83
- CHEMBL3039517
- SCHEMBL30403507
- DTXCID70160908
- EX-A426
- CHEBI:124917
- BCPP000178
- GLXC-90405
- ABP000954
- BDBM50524309
- NSC761188
- NSC800860
- s2626
- ZINC70466463
- (S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea
- AKOS027422721
- LY2603618(IC-83)
- ACN-053690
- BCP9000873
- CCG-264970
- CS-0472
- DB11662
- EBC-221027
- NSC-761188
- NSC-800860
- RL05730
- SDCCGSBI-0654427.P001
- CID11955855
- LY2603618 (IC-83)
- LY2603618;IC-83
- NCGC00343768-01
- AC-32839
- AS-56111
- BC638812
- BL166662
- CID:11955855
- HY-14720
- SMR004702821
- SID:170467345
- Checkpoint Kinase 2 Inhibitor LY2603618
- A8638
- LY2603618 - IC-83
- LY2603618(IC-83)?
- NS00072935
- SW219621-1
- J3.353.319E
- A11036
- A25224
- C77108
- D10397
- W-5770
- LY2603618 (IC-83)/IC-83
- 1-[5-bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea
- C582547
- BRD-K14109347-001-03-4
- BRD-K14109347-001-05-9
- Q27088510
- IC-83;LY 2603618;LY-2603618
- Urea, N-(5-bromo-4-methyl-2-((2S)-2-morpholinylmethoxy)phenyl)-N'-(5-methyl-2- pyrazinyl)-
- (S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea.
- 3-{5-bromo-4-methyl-2-[(2S)-morpholin-2-ylmethoxy]phenyl}-1-(5-methylpyrazin-2-yl)urea
- N-(5-bromo-4-methyl-2-{[(2S)-morpholin-2-yl]methoxy}phenyl)-N'-(5-methylpyrazin-2-yl)urea
- IC-83, LY 2603618, LY-2603618, 911222-45-2
- 1-(5-bromo-4-methyl-2-{[(2S)-morpholin-2-yl]methoxy}phenyl)-3-(5-methylpyrazin-2-yl)urea
- 1-(5-bromo-4-methyl-2-S-(morpholin-2-yl-methoxy)-phenyl)-3-(5-methyl-pyrazin-2-yl)-urea
- 3-(5-bromo-4-methyl-2-(((2S)-morpholin-2-yl)methoxy)phenyl)-1-(5-methylpyrazin-2-yl)urea
- 3-(5-Bromo-4-methyl-2-[(2s)-morpholin-2-ylmethoxy]phenyl)-1-(5-methylpyrazin-2-yl)urea
- 3-(5-bromo-4-methyl-2-{[(2S)-morpholin-2-yl]methoxy}phenyl)-1-(5-methylpyrazin-2-yl)urea
- n-(5-bromo-4-methyl-2-((2s)-2-morpholinylmethoxy)phenyl)-n'-(5-methyl-2-pyrazinyl)urea
- N-[5-Bromo-4-methyl-2-[(2S)-2-morpholinylmethoxy)phenyl]-N'-(5-methyl-2-pyrazinyl)urea
- 1-(5-BROMO-4-METHYL-2-((2S)-MORPHOLIN-2-YLMETHOXY)PHENYL)-3-(5-METHYLPYRAZIN-2-YL)UREA
- 1-[2-[[(2S)-Morpholine-2-yl]methoxy]-4-methyl-5-bromophenyl]-3-(5-methyl-2-pyrazinyl)urea
- 1-[2-[[(2S)-Morpholine-2alpha-yl]methoxy]-4-methyl-5-bromophenyl]-3-(5-methyl-2-pyrazinyl)urea
- LY-2603618|||1-[5-Bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea
- N-(5-bromo-4-methyl-2-(((2S)-morpholin-2-yl)methoxy)phenyl)-N'-(5-methylpyrazin-2-yl)urea
- UREA, N-(5-BROMO-4-METHYL-2-((2S)-2-MORPHOLINYLMETHOXY)PHENYL)-N'-(5-METHYL-2-PYRAZINYL)-